Page last updated: 2024-10-31

neostigmine and Hamartoma

neostigmine has been researched along with Hamartoma in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Hamartoma: A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emson, HE1

Other Studies

1 other study available for neostigmine and Hamartoma

ArticleYear
Extrathoracic angiofollicular lymphoid hyperplasia with coincidental myasthenia gravis.
    Cancer, 1973, Volume: 31, Issue:1

    Topics: Adolescent; Biopsy; Female; Hamartoma; Humans; Hyperplasia; Lymph Nodes; Myasthenia Gravis; Neostigm

1973